NATF strives to bring you the most relevant information in the field of thrombosis research and cardiovascular-related illnesses, which includes topics on thrombosis, stroke prevention, atrial fibrillation, and acute coronary syndrome.

A DOAC Deep Dive: Rivaroxaban

For the past several decades, warfarin has been the go-to anticoagulant for doctors, but new treatments have recently emerged in…

Anticoagulant Reversal

When deciding which anticoagulant to prescribe, physicians often are concerned about reversal. At the moment, only warfarin and dabigatran have…